We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:TSHA
​
​
logo

Taysha Gene Therapies (TSHA)

Nasdaq • TSHA • US8776191061

4.34Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 23.7% of free float sold short, 11.4 days to cover, cost to borrow 0.44%. Sign up for live short interest data.

Market Cap

1.41b USD | # 4448 in US

Volume

3.6m shares | 18.02m USD

Shares Outstanding

325.83m

Free Float Shares

71.39% | 232.62m

News

TSHA key data

Taysha Gene Therapies (Nasdaq: TSHA) has a market capitalization of $1.41B. Last close $4.34 (as of 2026-11-09); 52-week range $3.46 to $7.30. ORTEX data as of 2026-10-22: short interest was 23.65% of free float, 11.4 days to cover and the average cost to borrow was 0.44%. Sign up for live short interest data.

  • TSHA news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.